New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
06:58 EDTEMREmerson reports total three-month orders growth for January 0%-5%
Trailing three-month orders growth reflected demand improvement in total, with varied trends among businesses and end markets. Orders acceleration in Climate Technologies and improved trends in Process Management offset weakness in Industrial Automation and the embedded computing and power business. Underlying orders growth, excluding favorable currency translation of 1 percentage point, increased 1%. Industrial Automation orders decreased, as weakness continued in industrial goods end markets. Process Management orders growth accelerated. Order trends remained unchanged in Network Power, with mixed trends among businesses and end markets. Strong orders growth in Climate Technologies reflected improving market conditions in all regions.
News For EMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
10:18 EDTEMROptions with increasing implied volatility
Subscribe for More Information
January 26, 2015
09:58 EDTEMREmerson reports 3 months end December orders down 5% to flat
Subscribe for More Information
January 22, 2015
10:03 EDTEMROn the Fly: Analyst Initiation Summary
Subscribe for More Information
10:03 EDTEMROn the Fly: Analyst Downgrade Summary
Subscribe for More Information
07:57 EDTEMREmerson downgraded at BofA/Merrill
As previously reported, BofA/Merrill downgraded Emerson to Underperform from Neutral. The firm reduced forecasts below consensus based on expectations Process organic growth will decline in 2016 and 2017 and pressure the stock multiple. Price target lowered to $62 from $66.
06:51 EDTEMREmerson downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
06:33 EDTEMREmerson downgraded to Neutral from Outperform at RW Baird
Subscribe for More Information
January 21, 2015
16:12 EDTEMREmerson initiated with a Neutral at UBS
Target $62.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use